Related Experiment Video
Updated: Jul 8, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
374
RNA m6A modifications regulate crosstalk between tumor metabolism and immunity
Jinghua Gu1,2, Huake Cao1,2, Xiaoli Chen3
1School of Life Sciences, Anhui Medical University, Hefei, China.
Wiley Interdisciplinary Reviews. RNA
|December 20, 2023
Summary
N-methyladenosine (m6A) modifications influence cancer cell metabolism and immune cell function. Understanding these RNA changes offers new therapeutic strategies for cancer by targeting tumor cell behavior and immunity.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- N-methyladenosine (m6A) RNA modifications are increasingly recognized for their role in cancer.
- m6A impacts tumor cell metabolism and the function of tumor-infiltrating immune cells.
Purpose of the Study:
- To review the intricate connections between RNA m6A modifications, tumor cell metabolism, and immune cell behavior.
- To explore the reciprocal regulatory axes: 'RNA m6A-tumor cell metabolism-immune cell behavior' and 'RNA m6A-immune cell behavior-tumor cell metabolism'.
- To discuss factors influencing m6A modifications within the tumor microenvironment, including hypoxia and cytokines.
Main Methods:
- Literature review and synthesis of existing research on m6A modifications in cancer.
- Analysis of the interplay between m6A, cancer metabolism, and immune responses.
- Discussion of the impact of tumor microenvironment factors on m6A.
Main Results:
- RNA m6A modifications are pivotal in mediating interactions between tumor metabolism and anti-tumor immunity.
- m6A influences cancer cell metabolism and the differentiation/activity of immune cells.
- Hypoxia and cytokines in the tumor microenvironment affect RNA m6A levels.
Conclusions:
- RNA m6A modifications are a critical link between cancer metabolism and immunity.
- Targeting m6A modifications presents a promising avenue for novel cancer therapies.
- m6A-based strategies could simultaneously address cancer cell malignancy and bolster anti-tumor immunity.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K